MA
CRL icon

MUFG Americas’s Charles River Laboratories CRL Stock Holding History

MUFG Americas’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-80
Closed -$30K – 815
2021
Q4 		$30K Buy
+80
New +$31.1K ﹤0.01% 621
2019
Q2 		– Sell
-252
Closed -$37K – 801
2019
Q1 		$37K Buy
+252
New +$33.1K ﹤0.01% 550
2014
Q1 		– Sell
-97
Closed -$5K – 1132
2013
Q4 		$5K Sell
97
-106
-52% -$5.32K ﹤0.01% 974
2013
Q3 		$9K Sell
203
-230
-53% -$10.6K ﹤0.01% 1016
2013
Q2 		$18K Buy
+433
New +$18.6K ﹤0.01% 1310

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MUFG Americas's CRL Position: Q1 2022 in Review

MUFG Americas sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 80 shares — an estimated $30K sold.

MUFG Americas first reported a position in CRL in Q2 2013 and held it in 5 quarters. The position peaked at $37K in Q1 2019. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • MUFG Americas reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • MUFG Americas sold 80 Charles River Laboratories shares in Q1 2022, an estimated $30K.
  • MUFG Americas first reported a position in Charles River Laboratories in Q2 2013 and held it in 5 quarters.
  • MUFG Americas's Charles River Laboratories position peaked at $37K in Q1 2019.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on MUFG Americas's 13F filing for Q1 2022, filed 6 May 2022.